The FTSE 100 started the week on a positive note as UK shares traded higher, with investors eagerly awaiting key data releases. However, SkinBio Therapeutics saw its shares plummet, following disappointing news that its acne treatment failed to meet primary endpoints in a clinical trial. The market remains cautiously optimistic amidst ongoing economic uncertainties.

Read more at Investing.com: FTSE 100 today: UK shares start week in green ahead of key data; SkinBio slumps